| INTRODUCTION
Recent population studies have shown that placenta accreta spectrum (PAS) disorders remain undiagnosed before delivery in half 1, 2 to twothirds of cases. 3 In a series from specialist diagnostic units in the USA, around one-third of cases of PAS disorders were not diagnosed during pregnancy. 4 Maternal mortality and morbidity are reduced when women with PAS disorders, particularly the invasive forms-placenta increta or percreta-deliver in a center of excellence by a multidisciplinary care team with experience in managing the surgical risks and perioperative challenges presented by these disorders. [5] [6] [7] [8] Transfer to a center of excellence, however, relies on both recognition of the women at risk of PAS disorders and on accurate prenatal diagnosis.
Current prenatal diagnosis rests on subjective interpretation of "typical" sonographic findings or signs with two-dimensional (2D)
grey-scale and color Doppler imaging. Many signs have been reported in the literature with varying descriptions as to their sensitivity and specificity. 9 The published literature is difficult to interpret because of several problems in the definition, terminology, and diagnosis of this disorder. 10 To improve consistency and allow appropriate comparison of different imaging markers, panels of experts have published consensus statements that aim to standardize the descriptions and minimum requirements for an ultrasound scan to diagnose PAS disorders. 11, 12 Magnetic resonance imaging (MRI), although widely employed, has yet to clearly demonstrate a significant improvement in management or pregnancy outcomes. 13 MRI is expensive and requires expertise that is rarely available in most low-income countries and many mediumincome countries. MRI is currently only recommended as an adjunct to ultrasound imaging by many professional bodies throughout the world including the Royal College of Obstetricians and Gynaecologists (RCOG) in the UK. 14 Irrespective of the imaging modality used, prenatal diagnosis of PAS disorders remains subjective, with accuracy depending on the experience of the operator, which has so far been limited by the rarity of the condition and the lack of training programs similar to those existing for the screening of fetal aneuploidies and fetal anatomical defects, such as congenital heart defects.
PAS disorders are a growing obstetric issue and with the continuous increase in cesarean deliveries more studies are being published yearly. The definitive diagnosis, however, can only be made clinically at delivery and should be confirmed by histopathology wherever possible. This chapter reviews the various prenatal diagnostic techniques described in the international literature for the diagnosis of PAS disorders. As abnormal placentation is a spectrum disorder including both abnormal adherence (placenta creta) and abnormal invasion (placenta increta and placenta percreta), the term PAS disorders is used here as the overarching descriptor of the whole condition. 
| ULTRASOUND IMAGING

| The ultrasound signs
The first ultrasound sign suggesting PAS disorders described by greyscale ultrasound imaging was the "loss of the hypoechoic retroplacental (clear) zone," which is thought to represent an abnormal extension of the placental villi through the decidua basalis into the myometrium. 17 The presence of numerous large or irregular lacunae directly connected to a feeding vessel has also been repeatedly reported as a reliable grey-scale ultrasound sign. 17, 18 However, throughout the literature the reported sensitivity of grey-scale imaging ranges widely between 50% and 87%. 9, [16] [17] [18] [19] The incorporation of CDI has enabled better visualization of the uteroplacental circulation 9, 16, 17, 20, 21 21 indicate that the sensitivity and specificity of grey-scale imaging alone in screening for placenta previa accreta are high when performed by expert operators.
In an attempt to reduce errors due to the subjectivity involved in making this diagnosis and ensure that all operators are using the same description for the same sign, the European Working Group on Abnormally Invasive Placenta (EW-AIP) recently proposed a standardized description and name for all the ultrasound signs used for the prenatal diagnosis of placenta accreta. 12 These are shown in Adapted from D'Antonio et al. 9 and D'Antonio et al. 28 an ultrasound assessment to diagnose PAS disorders. 11 A systematic review using this new standardized description for ultrasound examination of PAS disorders found that the loss of the clear zone (62.1%) and the presence of bridging vessels (71.4%) were the most common ultrasound signs found in cases of placenta creta. For placenta increta, a loss of the clear zone (84.6%) and subplacental hypervascularity (60%) were the most common ultrasound signs, whereas placental lacunae (82.4%) and subplacental hypervascularity (54.5%) were the most common ultrasound signs in placenta percreta. 15 Due to wide heterogeneity in terminology used to describe the grades of PAS disorders and differences in study design, no ultrasound sign or combination of ultrasound signs is specific for the depth of accreta placentation. [15] [16] [17] In addition, accreta implantation is not homogeneous, but combines adherent and invasive villous tissue. Within this context, it is pivotal that authors of prenatal diagnosis series provide detailed data on the degree of depth of villous invasion for each case included in their study. It is also essential that future studies use standardized criteria for ultrasound imaging, clinical diagnosis, and pathological examination to ensure good audit of clinical practice, research, improved teaching, and most importantly, better patient outcome.
| Models for improving ultrasound prediction
A single-center retrospective cohort of 184 women with one or more prior cesarean deliveries and an ultrasound diagnosis of placenta previa or low-lying placenta used linear logistic regression and multiparametric analyses to generate a predictive equation. The analysis was performed using a receiver operating characteristic (ROC) curve, which indicated that the combination of the smallest sagittal myometrial thickness, intraplacental lacunae, and bridging vessels, in addition to the number of previous cesarean deliveries and placental location, generates an area under the curve of 0.87 (95% CI 0.80-0.95). 22 Each parameter was weighted to create a nine-point scale in which a score of 0-9 (placenta accreta index)
provided a probability of invasion that ranged from 2% to 96%, respectively. A similarly designed study of 92 cases of suspected accreta found that the area under the ROC curve was 0.85, with contribution from three variables: placenta previa, number of previous cesarean deliveries, and ultrasound suspicion. 23 These studies indicate that combining diagnostic features associated with PAS disorders through mathematical modeling may improve accuracy of prenatal diagnosis compared with ultrasound alone. However, like most single center studies, these may have overestimated accuracy because they are conducted in centers specialized in prenatal diagnostics, and the overall number of cases of PAS disorders included in these series is small. The authors of both studies have also not differentiated between adherent and invasive cases in their series, limiting the use of their data in clinical practice. In addition, the use of "morbidity adherent" to describe cases that are obviously invasive 22 is confusing and can lead to misinterpretation of the data.
T A B L E 2 Unified descriptors (EW-AIP suggestions) for ultrasound findings in placenta accreta spectrum (PAS) disorders. 
| Technical issues in the diagnosis of PAS disorders
| Transducer selection and approach
The ultrasound signs of abnormal placental invasion are most often described in the literature using transabdominal scanning and only 6 out of 14 cohort studies of placenta previa accreta reported on the use of transvaginal scanning (TVS). 16 TVS is often recommended to identify the cervical canal, internal os, and the relationship between the leading placental edge and the internal os; it can also be used for a focused evaluation of the lower uterine wall and the bladder interface. Transabdominal scans can be improved by selecting a higher frequency (5-9 MHz) transducer (linear if possible), and carefully "walking" the scar from one end to the other, keeping the transducer perpendicular to the uterine wall.
| Bladder filling
Ultrasound examination must be carried out with a full bladder 
| Probe pressure
Excessive probe pressure during transabdominal scanning can lead to the apparent loss of the retroplacental clear zone-one of the signs of invasive placentation. Therefore, this should be avoided. The loss of the retroplacental clear zone should be assessed with light probe pressure. 17 This pitfall is also much less likely to occur with TVS.
| Use of color flow mapping and power Doppler
Excessive vascularity of the lower uterine segment is associated with abnormal invasion but is an inherently subjective sign. The normal uteroplacental interface is quite vascular but color Doppler imaging evaluation of this area is not part of a routine examination. Even experienced operators often do not have a baseline understanding of normal flow; it is, therefore, difficult to assess increased flow.
Appropriate machine settings are essential. 24 This includes the correct gain setting for the individual woman, often referred to as the subnoise gain. This is the gain value where any artifact just disappears on reducing the level. This individual setting allows for optimal visualization of the flow despite differences in tissue attenuation (e.g.
between different amounts of abdominal adipose tissue). Likewise, the correct velocity scale is crucial to appropriate visualization of the vasculature: if too high, low flow will not be seen; if too low, an "aliasing" artifact will appear. Appropriate machine settings and a full awareness of how changes to these settings will affect the appearance of the vascularity are pivotal to avoid these pitfalls.
| THE ROLE OF MRI IN THE DIAGNOSIS OF PAS DISORDERS
MRI has been used increasingly for the prenatal diagnosis of PAS disorders. [25] [26] [27] [28] [29] The main MRI features of placenta accreta include abnormal uterine bulging, dark intraplacental bands on T2-weighted imaging, heterogeneous signal intensity within the placenta, disorganized placental vasculature, and disruption of the uteroplacental zone ( It has been suggested that MRI is particularly valuable for detecting parametrial invasion by villous tissue. 26 However, parametrial invasion is not commonly reported by most authors. MRI may be considered in cases with a posterior placenta and suspicion of percreta.
Increased depth and fetal parts may preclude a complete ultrasound evaluation of the uteroplacental interface of a posterior placenta. MRI is unaffected by these factors. 27 As the reported diagnostic performance of ultrasound imaging is high in expert hands, it is debatable whether MRI can substantially add to the prenatal diagnosis of PAS disorders. Use of safe contrast agents may improve the diagnostic performance of MRI in the future.
| PRENATAL SCREENING FOR PAS DISORDERS
| Clinical screening
Several risk factors for PAS disorders have been identified. These include advanced maternal age, multiparity, previous uterine surgery including curettage, assisted reproductive techniques, and previous cesarean delivery. 19 The most commonly described risk factor is the combination of previous cesarean delivery and placenta previa. 30 This combination also poses other problems, including increased risk of prenatal bleeding, access to the fetus for delivery, and the relatively poor contractility of the lower segment leading to greater postpartum blood loss.
The prevalence of PAS disorders in the general population of pregnant women is around 1.7 per 10 000 pregnancies. 30, 31 However, the incidence of placenta previa accreta is 4.1% in women with one prior cesarean delivery and 13.3% in women with two or more previous cesareans, 16 and continues to rise with the number of prior cesareans. 30 Thus, focusing the screening of PAS disorders on this group is more productive in terms of diagnostic yield. All women found to have an anterior low-lying (placental edge <2 cm from the internal cervical os after 16 weeks of gestation) or placenta previa should be asked if they have had a previous cesarean delivery during prenatal consultations and, if they do, they should be referred to a center with expertise in the prenatal diagnosis of PAS disorders.
| Midpregnancy ultrasound screening
Ultrasound screening for PAS disorders is not routinely taught during ultrasound training courses. Introducing such a screening program has been discussed but never implemented. We are not aware of ultrasound courses that train ultrasonographers who perform routine midtrimester ultrasound for detailed fetal anatomy examination in screening for PAS disorders. Identification of an anterior low-lying placenta or an anterior previa or a placenta previa covering the internal os in a woman with a history of previous cesarean delivery should prompt referral to the most experienced operator available (preferably with expertise in diagnosis of PAS disorders) for a more detailed scan to look for signs. All sonographers should be aware of the risk of PAS disorders, especially with an anterior low placenta or placenta previa, and should be aware of the referral pathway for further investigation if they have any concerns.
There are no prospective data on the ultrasound screening of PAS disorders at the routine midtrimester ultrasound examination by nonexpert operators. 16 Introducing such a screening program requires careful consideration, but is increasingly necessary owing to the constant rise in the number of cesarean deliveries.
| First trimester screening for PAS disorders
Recently, it has been suggested that cesarean scar pregnancy represents a precursor of one of the different grades of PAS disorders. [32] [33] [34] Implantation of the gestational sac into a previous cesarean delivery scar is diagnosed using the following three criteria on TVS 35 :
1. Gestational sac located anteriorly at the level of the internal os within a visible myometrial defect (thin or absent myometrium)
at the site of the previous lower segment cesarean delivery scar.
Evidence of functional trophoblastic/placental circulation on color
Doppler examination, characterized by high-velocity (peak velocity >20 cm/s) and low-impedance (pulsatility index <1) blood flow.
3. To distinguish from a spontaneous abortion in progress look for a negative "sliding organs sign," defined as the inability to displace the gestational sac from its position at the level of the internal os using gentle pressure applied by the transvaginal probe.
A recent systematic review and meta-analysis showed that cesarean scar pregnancy with positive embryonic/fetal heart activity managed expectantly is associated with a high rate of maternal morbidities including severe hemorrhage, early uterine rupture, hysterectomy, and severe PAS disorders. 36 However, this review included only 69 cases and thus there is still limited evidence on the natural history of cesarean scar pregnancy and in particular on the incidence of PAS disorders in women diagnosed with cesarean scar pregnancy in the first trimester of pregnancy.
Overall, a cesarean scar pregnancy, even if not accreta, is associated with a very high risk of obstetric complications due to the consequences of a major placenta previa, i.e. massive obstetric hemorrhage.
Thus, women diagnosed in the first trimester with a cesarean scar pregnancy should be counselled regarding the high risk of complications including hysterectomy. Because of the high risk in continuing the pregnancy, termination in the first trimester should be considered. 37 The most experienced operator available should follow up the patient, preferably one with expertise in the diagnosis of PAS disorders.
| Biomarkers of PAS disorders
Several placental and fetal hormones routinely used in the screening of with normal controls. 42 Other biomarkers have been investigated retrospectively in the serum of women diagnosed with PAS disorders at delivery, but their lack of availability in hospital laboratories limits their use in clinical practice. Overall, biomarkers could be used with ultrasound imaging to screen for PAS disorders prenatally in a model similar to that used for aneuploidy screening; however, the benefit of this remains unknown until more prospective data are available.
| LIMITATIONS OF PRENATAL DIAGNOSIS
One should remember that prenatal diagnosis of PAS disorders is not a histopathological diagnosis. Small areas of abnormal invasion have been reported even in asymptomatic women, and are of little clinical significance. 43 Similarly a simply adherent placenta will not require major surgery and can often be managed conservatively. In such cases, lack of ultrasound signs despite histopathological evidence of abnormal invasion may be interpreted as "failure" of prenatal diagnosis by ultrasound. It can be argued that the purpose of prenatal diagnosis is to forewarn the obstetric team of the probability of significant maternal morbidity. Therefore, the aim of prenatal imaging should be to detect PAS disorders of clinical significance such as placenta increta and percreta. [10] [11] [12] [15] [16] [17] It is therefore paradoxical and confusing that an increasing number of authors of prenatal diagnostic series include in their cohort both superficially adherent and invasive placenta under the morbidly adherent category. In addition, as many of these authors do not provide accurate clinical data on the differential diagnosis of the different categories of PAS disorders, it is difficult to separate retrospectively the noninvasive placenta accreta from the retained placenta. This has an impact on the epidemiology data and on determining the diagnostic accuracy of ultrasound and MRI.
A significant proportion of cases of placenta previa are associated with PAS disorders, particularly if the uterus is scarred and the placenta is anterior and/or covering the cervix. Even if no villous tissue is invading the uterine myometrium, access to the fetus is complicated by the position of the underlying placenta, the lower uterine segment adjacent to the placenta is highly vascularized, and major hemorrhage can still occur. It would be incorrect to believe that major morbidity should be expected only if prenatal diagnosis of PAS disorders has been made.
It is also important to remember that although imaging is the best investigation modality available for prenatal identification of invasive placentation, the sensitivity and specificity are not 100%. In cases of false-negative prenatal diagnosis, the surgeon performing the cesarean delivery will use a low transverse uterine incision and this may lead to massive intraoperative hemorrhage, even before the fetus is delivered. By contrast, a false-positive diagnosis of PAS disorders will lead to an unnecessary midline vertical skin incision and a fundal uterine incision, thus increasing the risk of intraoperative and postoperative complications and the risk of PAS disorders and uterine rupture in subsequent pregnancies. 16 
| RECOMMENDATIONS
Recommendations for prenatal diagnosis and screening of PAS disorders are given in Table 3 .
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T A B L E 3 Recommendations for prenatal diagnosis and screening of placenta accreta spectrum (PAS) disorders.
Recommendations
Resource settings
Quality of evidence and strength of recommendation
Ultrasonography is a relatively inexpensive and widely available imaging modality and therefore should be the first line for the diagnosis of PAS disorders
All High and Strong
Women diagnosed with cesarean scar pregnancy in the first trimester should be counselled regarding the high risk of requiring a hysterectomy owing to PAS disorders. They should be followed up by the most experienced operator available, preferably one with expertise in diagnosis of PAS disorders
At the mid-trimester examination for fetal anomaly, all women should be asked if they have had a previous cesarean delivery. If so, this should prompt careful assessment of the placental implantation site especially if it is anterior, low lying, or previa All Medium and Strong
The ultrasound signs observed for the diagnosis of PAS disorders should be described using standardized protocols
All Medium and Strong
The recorded presence or absence of each ultrasound sign will be influenced by the operator's interpretation of what constitutes that marker All High and Strong MRI is not essential for making a prenatal diagnosis of suspected PAS disorders but may be useful in evaluating the pelvic extension of a placenta percreta or areas difficult to evaluate on ultrasound High-income Medium and Weak
